High Dose Nimodipine Treatment Adjunct - 1

Phase 2

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000332
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Detailed Description

Not available

Study Timeline

• Study Start: 1998-05
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Primary Completion: 2000-01
• Study Completion: 2000-04
• Status Verified: 2002-12
• Last Update Submitted: 2017-02-23
• Last Update Posted: 2017-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart rate
Stimulated and non-stimulated craving
Stimulated and non-stimulated withdrawal
Anxiety, depression

Trial Locations

Locations (1)

Washington DC VA; 🇺🇸 Washington, District of Columbia, United States